|
|
L B Jakeman, J Winer, G L Bennett, C A Altar, N Ferrara
J Clin Invest. 1992;
89(1):244
doi:10.1172/JCI115568
Abstract |
Full text
| PDF

V
ascular endothelial growth factor (VEGF) is a secreted heparin-binding mitogen; its growth-promoting activity is limited to vascular endothelial cells in vitro and VEGF also stimulates angiogenesis in vivo. To identify target cells for VEGF and investigate the potential physiological role of this factor, iodinated recombinant human VEGF (125I-rhVEGF) was used for in vitro ligand autoradiography on tissue sections from adult rats. 125I-rhVEGF exhibited saturable, displaceable binding to a single class of sites with high affinity and low capacity in all tissues and organs examined. Colocalization of 125I-rhVEGF binding with Factor VIII-like immunoreactivity demonstrated binding sites associated with vascular endothelial cells of both fenestrated and nonfenestrated microvessels and the endothelium of large vessels, while no displaceable binding was evident on nonendothelial cells. Specific binding was associated with quiescent as well as proliferating vessels. These findings support the hypothesis that VEGF plays a specific role in both the maintenance and in the induction of growth of vascular endothelial cells.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(119)
| Title and authors |
Publication |
Year |
Targeting angiogenesis in ovarian cancer
Jordan Schmitt, Daniela Matei
|
Cancer Treatment Reviews
|
2011 |
Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
Sònia Tugues, Sina Koch, Laura Gualandi, Xiujuan Li, Lena Claesson-Welsh
|
Molecular Aspects of Medicine
|
2011 |
Signal transduction by vascular endothelial growth factor receptors
Sina Koch, Sònia Tugues, Xiujuan Li, Laura Gualandi, Lena Claesson‑Welsh
|
Biochem. J.
|
2011 |
Effects of vascular endothelial growth factor on porcine preimplantation embryos produced by in vitro fertilization and somatic cell nuclear transfer
D. Biswas, E.M. Jung, E.B. Jeung, S.H. Hyun
|
Theriogenology
|
2011 |
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
Samar Masoumi Moghaddam, Afshin Amini, David L. Morris, Mohammad H. Pourgholami
|
Cancer Metastasis Rev
|
2011 |
Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer
Jennifer Delli Carpini, Amer K. Karam, Leslie Montgomery
|
Angiogenesis
|
2010 |
Molecular imaging of angiogenesis with SPECT.
Ingrid Dijkgraaf, Otto C Boerman
|
Eur J Nucl Med Mol Imaging
|
2010 |
Expressions of Vascular Endothelial Growth Factor and Nitric Oxide Synthase III in the Thyroid Gland of Ovariectomized Rats Are Upregulated by Estrogen and Selective Estrogen Receptor Modulators
Luiz Felipe Bittencourt de Araujo, Renata Grozovsky, Mário José dos Santos Pereira, Jorge José de Carvalho, Mário Vaisman, Denise P. Carvalho
|
Thyroid
|
2010 |
Growth Factors and Gene Expression of Stem Cells: Bone Marrow Compared With Peripheral Blood
Dennis G. Smiler, Muna Soltan, Christie Soltan, Connie Matthews
|
Implant Dentistry
|
2010 |
Cerebral arteriovenous malformations. Part 1: cellular and molecular biology
Parham Moftakhar, Jason S. Hauptman, Dennis Malkasian, Neil A. Martin
|
Neurosurgical FOCUS
|
2009 |
|